Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Blood|January 1, 1993
Transgenic mice expressing human sickle hemoglobin are partially resistant to rodent malariaH L Shear, E F Roth, M E Fabry, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 24, 2007
Inhibition of CETP by torcetrapib attenuates the atherogenicity of postprandial TG-rich lipoproteins in type IIB hyperlipidemiaMaryse Guerin, Wilfried Le Goff, Emilie Duchene, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 19, 2019
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal AntibodiesEllen Q Wang, Jack F Bukowski, Carla Yunis, et al.
Psychiatry Research|April 20, 2001
Estimating the consequences of anti-psychotic induced weight gain on health and mortality rateK R Fontaine, M Heo, E P Harrigan, et al.
Annals of Internal Medicine|June 1, 1993
Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemiaR H Bradford, M Downton, A N Chremos, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1992
Lovastatin and coadministered antihypertensive/cardiovascular agentsJ L Pool, C L Shear, M Downton, et al.
The American Journal of the Medical Sciences|September 1, 1989
Risk factors in early life as predictors of adult heart disease: the Bogalusa Heart StudyG S Berenson, S R Srinivasan, S M Hunter, et al.
American Journal of Epidemiology|August 1, 1986
Cigarette smoking initiation and longitudinal changes in serum lipids and lipoproteins in early adulthood: the Bogalusa Heart StudyD S Freedman, S R Srinivasan, C L Shear, et al.
Genetic Epidemiology|January 1, 1986
Description of a large pedigree with an adverse lipoprotein cholesterol phenotype: the Bogalusa Heart StudyP A Rosenbaum, C I Amos, C L Shear, et al.
American Journal of Public Health|May 1, 1987
Persistence of juvenile-onset obesity over eight years: the Bogalusa Heart StudyD S Freedman, C L Shear, G L Burke, et al.
Pageof 11